2005
DOI: 10.1016/j.jtbi.2004.08.002
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of pathways for progression of heterogeneous breast tumors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
43
1
1

Year Published

2007
2007
2016
2016

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(45 citation statements)
references
References 24 publications
(32 reference statements)
0
43
1
1
Order By: Relevance
“…This approach is supported by studies indicating that DCIS and invasive breast cancer can develop independently (23,24). However, because the natural history of DCIS is poorly understood (9, 10), we also carried out two sensitivity analyses.…”
Section: Discussionmentioning
confidence: 89%
“…This approach is supported by studies indicating that DCIS and invasive breast cancer can develop independently (23,24). However, because the natural history of DCIS is poorly understood (9, 10), we also carried out two sensitivity analyses.…”
Section: Discussionmentioning
confidence: 89%
“…Previous mathematical and computational models of DCIS have focused on a single breast duct and have been successful in recapitulating certain features of the spatio-temporal dynamics of proliferating and motile tumor cells at this microscale [18][19][20][21][22][23][24][25][26][27][28][29], and have even, in some cases, been capable of extrapolating their results to predictions of macroscopic growth features [24] or invasive potentials as a function of grade [29]. Here we adopt a multiscale approach to predict growth and size of the volume of breast containing ducts with DCIS based on molecular measurements from histopathology of individual patient tumors.…”
Section: Methodsmentioning
confidence: 99%
“…Although DCIS is considered a nonobligate precursor to invasive breast cancer, mathematical models of progression suggest that DCIS and IDC may develop through separate but parallel pathways from a common progenitor (27). Different models that have accurately incorporated progression data collectively suggest multiple pathways of progression (28).…”
Section: Intralesional Heterogeneity Of Premalignant Lesionsmentioning
confidence: 99%